中國醫藥大學機構典藏 China Medical University Repository, Taiwan:依題名瀏覽

瀏覽全部
	社群與類別
	題名
	日期
	作者
	資料類型

相關新聞
‧「中國醫藥大學機構典藏系統」資料上傳說明會 ‧中國醫藥大學機構典藏系統作業要點

相關連結
‧中國醫藥大學機構典藏同意書曁上傳委託書 ‧機構典藏計畫網站(NTUR Wiki) ‧臺灣學術機構典藏(TAIR) ‧出版社及期刊政策查詢 ‧SHERP RoMEO出版社著作權查詢 ‧中國醫藥大學 ‧中國醫藥大學圖書館

中國醫藥大學機構典藏 China Medical University Repository, Taiwan > 依題名瀏覽

跳至: [中文] [數字0-9] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]

請輸入前幾個字:

顯示項目27801-27825 / 54961. (共2199頁)
<< < 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 > >>
每頁顯示[10|25|50]項目

日期	題名	作者
1999	YC-1 potentiates the antiplatelet effect of hydrogen peroxide via sensitization of soluble guanylate cyclase	Wu, CC; Kuo, SC; Lee, FY; Teng, CM
2004	YC-1 prevents sodium nitroprusside-mediated apoptosis in vascular smooth muscle cells	Pan, SL; Guh, JH; Chang, YL; Kuo, SC; Lee, FY; Teng, CM
2005	YC-1 suppresses constitutive nuclear factor-kappa B activation and induces apoptosis in human prostate cancer cells	Huang, YT; Pan, SL; Guh, JH; Chang, YL; Lee, FY; Kuo, SC; Teng, CM
	YC-1 supresses constitutive nuclear factor-kB activation and induces apoptosis in human prostate cancer cells?	(Yao-Ting Huang); (Shiow-Lin Pan); (Jih-Hwa Guh); (Ya-Ling Chang); (Fang-Yu Lee); 郭盛助(Sheng-Chu Kuo); (Che-Ming Teng)?
2005	YC-1 [3-(5 '-hydroxymethyl-2 '-furyl)-1-benzyl indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G(0)-G(1) in human hepatocellular carcinoma cells	Wang, SW; Pan, SL; Guh, JH; Chen, HL; Huang, DM; Chang, YL; Kuo, SC; Lee, FY; Teng, CM
2005-07	YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models	潘秀玲(Pan, S.L.); 顧記華(Guh, J.H.); 彭婕妤(Chieh-Yu Peng); 王士維(Wang, S.W.); 張雅玲(Chang, Y.L.); (Cheng FC); (Chang JH); 郭盛助(Sheng-Chu Kuo); 李芳裕(Lee, F.Y.); 鄧哲明(Teng, C.M.)*
2006-01	YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9	劉奕男(Liu, Y.N.); 潘秀玲(Pan, S.L.); 彭婕妤(Chieh-Yu Peng); 顧記華(Guh, J.H.); 黃東明(Huang, D.M.); 張雅玲(Chang, Y.L.); 林俊宏(Lin, C.H.); 白惠珍(Pai, H.C.); 郭盛助(Sheng-Chu Kuo); 李芳裕(Lee, F.Y.); 鄧哲明(Teng, C.M.)*
2006	YC-1 [3-(5’-Hydroxymethyl-2’-furyl)-1-benzyl indazole] inhibits neointima formation in ballon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9	(Yi-Nan Liu); (Shiow-Lin Pan); (Chienh-Yu Peng); (Jih-Hwa Guh); (Dong-Ming Huang); (Ya-Ling Chang); (Chun-Hung Lin); (Hui-Chen Pai); 郭盛助(Sheng-Chu Kuo); (Fang-Yu Lee); (Che-Ming Teng)
1999	YC-1 之苯并咪唑類緣化合物的合成及其抗血小板凝集活性; Synthesis and Antiplatelet Activity of Benzimidazole Analogs of YC-1	蔡勝忠; Sheng-Chung Tsai
1994	YC-1, A NOVEL ACTIVATOR OF PLATELET GUANYLATE-CYCLASE	KO, FN; WU, CC; KUO, SC; LEE, FY; TENG, CM
2010	YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway	洪靚娟(Chin-Chuan Hung); 劉宏輝(Horng-Huei Liou)*
2005	YC-1[3-(5 '-hydroxymethyl-2 '-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models	Pan, SL; Guh, JH; Peng, CY; Wang, SW; Chang, YL; Cheng, FC; Chang, JH; Kuo, SC; Lee, FY; Teng, CM
2008-02-29	YC-1的衍生物專一性抑制HER2/NEU過度表現乳癌細胞	魏宗德(Tzong-Der Way)
2000	YD-3, a novel inhibitor of protease-induced platelet activation	Wu, CC; Huang, SW; Hwang, TL; Kuo, SC; Lee, FY; Teng, CM
1999	YD-3之苯咪唑類緣化合物之合成及其抗血小板活性; Synthesis and Antiplatelet Activity of Benzimidazole Analogs of YD-3	張敬義; Jing-I Jang
2014-06	Yeast oropharyngeal colonization in human immunodeficiency virus-infected patients in central Taiwan	何茂旺(Mao-Wang Ho); (Yun-Liang Yang); (Chih-Chao Lin); 齊治宇(Chih-Yu Chi); (Hui-Ting Chen); 林伯昌(Po-Chang Lin); (Li-Yun Hsieh); 周家卉(Chia-Huei Chou); (Wen-Li Chu); (Chiou-Pyng Wu); (Tsai-Ling Lauderdale); 羅秀容*
1971-06	Yohimbine	明旭
2013-02	Young nasopharyngeal cancer patients with radiotherapy and chemotherapy are most prone to ischemic stroke risk	朱俊男(Chin-Nan Chu); 陳培君(Pei-Chun Chen); 白禮源(Li-Yuan Bai); 莫之欣; 宋鴻樟(Fung-Chang Sung); 陳尚文(Shang-Wen Chen)*
2005-07-31	YT-1及K3對血癌及肺癌細胞株抗癌機轉之探討	李妙蓉(Lee,Miau-Rong); 林錦芬(Lin, Chin-Fen)
2012-11	Yuwen02f1 suppresses LPS-induced endotoxemia and adjuvant-induced arthritis primarily through blockade of ROS formation, NFkB and MAPK activation	(Chun-Chieh Hsu); 連金城(Lien Jin Cherng); (Chia-Wen Chang); (Chien-Hsin Chang); 郭盛助(Sheng-Chu Kuo); (Tur-Fu Huang)
1966-01	Y大學的X教授	妙中痴人
2011-06-05	Z-DRUGS USE IN ELDERLY 老年人Z-DRUGS的使用	于怡文; 吳博倫(Po-Lun Wu); 林志學(Chih-Hsueh Lin); 張欽凱(Chin-Kan Chang); 吳錫金(Wu,Hsi-Chin); 林正介(Cheng-Chieh Lin); 林香汶(Margaret Hsiang-Wen Lin)
2011-09-25	Z-drugs utilization in Taiwan-population retrospective evaluation	于怡文; 林香汶(Margaret Hsiang-Wen Lin); 廖俊惠(Chun-Hui Liao)
2013-03-13	ZAK induces Cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA-4/ c-Jun transcriptional factor activation Contents	謝宥諒; (陳冬生); 黃志揚(Chih-Yang Huang); 陳冬生*
2006-07-19	ZAK induces H9c2 cardiomyblast cell apoptosis mediates through calcineurin/ NFAT signaling pathway activation without AngII signaling involvement.	黃志揚

顯示項目27801-27825 / 54961. (共2199頁)
<< < 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 > >>
每頁顯示[10|25|50]項目

資料載入中.....